SCHEMBL12514858

SCHEMBL12514858

CCc1ccc(-c2ccc(Br)s2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.47
TP53 P04637 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
WRN Q14191 1/20 0.38
PGR P06401 1/20 0.38
IKBKB O14920 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
APP P05067 3/20 0.36
EGFR P00533 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
PTPN1 P18031 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3280851 0.83 APP (0.46) TP53SMN1; SMN2WRNIKBKBAPP
SCHEMBL2778388 0.82 SNCA (0.61) SNCATP53RXFP1SMN1; SMN2PGR
SCHEMBL13430083 0.82 SNCA (0.48) SNCATP53RXFP1SMN1; SMN2PGR
SCHEMBL27807767 0.82 HRH3 (0.52) SNCAAPPESR1ESR2
SCHEMBL21980890 0.79 KDM4E (0.48) TP53SMN1; SMN2EGFRESR1
SCHEMBL15071811 0.79 KDM4E (0.48) TP53SMN1; SMN2EGFRESR1
SCHEMBL1102346 0.79 KDM4E (0.48) TP53SMN1; SMN2EGFRESR1
SCHEMBL1105468 0.78 SMN1; SMN2 (0.47) TP53SMN1; SMN2WRNPGRIKBKB
SCHEMBL19742352 0.78 SMN1; SMN2 (0.43) TP53SMN1; SMN2WRNIKBKBAPP
SCHEMBL18015719 0.78 TP53 (0.56) TP53APPESR1ESR2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9318706-B2 Laminated structure, method for producing same, and electronic element comprising same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-19 US disclosed
US-8716703-B2 Organic semiconductor transistor FUJI XEROX CO., LTD. (JP) 2014-05-06 US disclosed
US-8716703-B2 Organic semiconductor transistor FUJI XEROX CO., LTD. (JP) 2014-05-06 US disclosed
US-20130161589-A1 ORGANIC SEMICONDUCTOR TRANSISTOR FUJI XEROX CO., LTD. (JP) 2013-06-27 US disclosed
US-20130161589-A1 ORGANIC SEMICONDUCTOR TRANSISTOR FUJI XEROX CO., LTD. (JP) 2013-06-27 US disclosed
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME EPCAM, ITGA1, ITGB1 SNCA 1509/4885TP53 3701/4885RXFP1 4023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.